Aarti Pharmalabs Limited (AARTIPHARM) — Cash Flow Reinvestment Rate
Aarti Pharmalabs Limited (AARTIPHARM) has a Cash Flow Reinvestment Rate of 0.00x as of December 2023, reinvesting Rs0.00 (capex Rs0.00 ) from operating cash flow of Rs375.40 Million. Check how high is Aarti Pharmalabs Limited's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Aarti Pharmalabs Limited Cash Flow Reinvestment Rate (2023–2025)
Historical reinvestment intensity for Aarti Pharmalabs Limited across 3 annual periods. Explore Aarti Pharmalabs Limited cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Aarti Pharmalabs Limited (2023–2025)
Year-by-year capital reinvestment analysis for Aarti Pharmalabs Limited. For live market cap and broader valuation context, see AARTIPHARM market cap.
| Year | Reinvestment Rate | Total Reinvested (INR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.21x | Rs4.02 Billion | Rs3.32 Billion | Rs4.02 Billion | ▲ +32.0% |
| 2024 | 0.92x | Rs1.99 Billion | Rs2.16 Billion | Rs1.99 Billion | ▼ -12.9% |
| 2023 | 1.06x | Rs2.77 Billion | Rs2.63 Billion | Rs1.20 Billion | — |